Sen. Laura M. Murphy
Filed: 4/8/2021
 
 

 

 

 
10200SB1789sam001LRB102 11192 RJF 24590 a



1
AMENDMENT TO SENATE BILL 1789




2    AMENDMENT NO. ______. Amend Senate Bill 1789 by replacing 
3everything after the enacting clause with the following:

 
4    "Section 5. The Department of Healthcare and Family 
5Services Law of the
Civil Administrative Code of Illinois is 
6amended  by adding Sections 2205-35 and 2205-40 as follows:
 
7    (20 ILCS 2205/2205-35 new)
8    Sec. 2205-35. Generic prescription drug contracting. The 
9Department of Healthcare and Family Services shall implement 
10and develop a program to establish a State prescription 
11generic drug label for the purpose of increasing competition 
12in the generic drug market and lowering generic drug prices 
13for all purchasers. The Department shall contract with one or 
14more generic drug manufacturers to manufacture certain generic 
15drugs on behalf of the State and participating entities. The 
16Department shall adopt rules necessary to implement and 
 
 
10200SB1789sam001- 2 -LRB102 11192 RJF 24590 a

1administer the program created under this Section.
 
2    (20 ILCS 2205/2205-40 new)
3    Sec. 2205-40. State Generic Drug Label Task Force.
4    (a) There is hereby established the State Generic Drug 
5Label Task Force to study the cost savings of establishing a 
6State prescription generic drug label.
7    (b) The Task Force shall consist of the following members:
8        (1) one member of the House of Representatives 
9    appointed by the Speaker of the House of Representatives 
10    in consultation with the Minority Leader of the House of 
11    Representatives;
12        (2) one member of the Senate appointed by the 
13    President of the Senate in consultation with the Minority 
14    Leader of the Senate;
15        (3) one member who is a representative of the 
16    Department of Healthcare and Family Services appointed by 
17    the Director of Healthcare and Family Services;
18        (4) one member from a managed care organization 
19    appointed by the Director of Healthcare and Family 
20    Services; and
21        (5) one member who is a pharmacist appointed by the 
22    Director of Healthcare and Family Services. 
23    (c) Members of the Task Force shall serve without 
24compensation.
25    (d) The Department shall provide administrative support to 
 
 
10200SB1789sam001- 3 -LRB102 11192 RJF 24590 a

1the Task Force.
2    (e) The Task Force shall select from among its members of a 
3chairperson.  The Task Force shall convene and hold its first 
4meeting beginning in September 2021, and shall hold at least 
5one meeting per month until the issuance of the report of the 
6Task Force under subsection (f).
7    (f) The Task Force shall study the cost savings of 
8establishing a State prescription generic drug label, and all 
9relevant and related matters, and issue a report on its 
10findings to the Governor and the General Assembly on or before 
11December 31, 2021.
12    (g) This Section is repealed on January 1, 2023. 
 

13    Section 99. Effective date. This Act takes effect upon 
14becoming law.".